NDC 51662-1375
Famotidine 10 mg per 1 mL injection, solution
On the label: HF Acquisition Co. LLC. DBA HealthFirst. It's repackaged: HF Acquisition Co. LLC. DBA HealthFirst rebottles it from Fresenius Kabi, LLC's NDC 63323-739.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Fresenius Kabi USA, LLC | Melrose Park, IL, United States | Makes it and tests it | Problems found, fixed voluntarilyAug 24, 2023 · 13 inspections, 2 with FDA action |
Repackaging site
- HF Acquisition Co LLC, Mukilteo, WA, United States · relabels it
Recalls
- Nov 6, 2025 · Class I · Fresenius Kabi USA, LLC
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Lots: Lot #: 6133156, 6133194, Exp Date: 08/2026; 6133388, Exp Date: 10/2026. - Jun 17, 2020 · Class III · HF Acquisition Co. LLC
TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.
Lots: Lot #: 6122639, Exp. Date 08/2021
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Famotidine: every company that makes it
- Form
- injection, solution, intravenous
- Strength
- 10 mg per 1 mL
- Approval
- ANDA ANDA075813
- On the market since
- Dec 9, 2019
- Package NDCs
51662-1375-151662-1375-2- Official label
- DailyMed (National Library of Medicine), updated Oct 1, 2022
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?